APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,641 | -27.9% | 174,569 | +72.7% | 0.08% | +8.6% |
| Q2 2023 | $9,211 | +1161.8% | 101,111 | +814.0% | 0.07% | +775.0% |
| Q1 2023 | $730 | -55.0% | 11,063 | -64.7% | 0.01% | -60.0% |
| Q4 2022 | $1,623 | -99.9% | 31,382 | +12.6% | 0.02% | -16.7% |
| Q3 2022 | $1,903,000 | -18.7% | 27,862 | -46.2% | 0.02% | -4.0% |
| Q2 2022 | $2,340,000 | +1009.0% | 51,756 | +1148.6% | 0.02% | +1150.0% |
| Q1 2022 | $211,000 | -97.5% | 4,145 | -97.7% | 0.00% | -95.7% |
| Q4 2021 | $8,403,000 | +38.5% | 177,734 | -3.4% | 0.05% | +64.3% |
| Q3 2021 | $6,065,000 | +284.6% | 184,014 | +637.4% | 0.03% | +300.0% |
| Q2 2021 | $1,577,000 | +106.4% | 24,953 | +40.1% | 0.01% | +75.0% |
| Q1 2021 | $764,000 | +386.6% | 17,811 | +549.8% | 0.00% | +300.0% |
| Q4 2020 | $157,000 | -85.1% | 2,741 | -92.2% | 0.00% | -85.7% |
| Q3 2020 | $1,054,000 | +567.1% | 34,939 | +623.2% | 0.01% | +600.0% |
| Q2 2020 | $158,000 | -48.9% | 4,831 | -58.1% | 0.00% | -66.7% |
| Q1 2020 | $309,000 | +17.0% | 11,527 | +33.7% | 0.00% | +50.0% |
| Q4 2019 | $264,000 | -83.3% | 8,622 | -86.9% | 0.00% | -84.6% |
| Q3 2019 | $1,585,000 | +1315.2% | 65,809 | +1042.1% | 0.01% | +1200.0% |
| Q1 2019 | $112,000 | – | 5,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |